Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group
12.12.2022 - MIAMI BEACH, Fla., Dec. 12, 2022 (GLOBE NEWSWIRE) - Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous ...
Paul Caminiti Nicholas Leasure Eric Shahinian Tiago Reis Marques Exchange Commission While The Company Company Contact
Source: wallstreet-online.de